Top Stories1 month ago
Catalyst Pharmaceuticals Reports Growth Amid Generic Competition
Catalyst Pharmaceuticals (NASDAQ:CPRX) recently showcased significant growth within its rare disease portfolio, particularly for its lead product, Firdapse. During a discussion with Barclays life sciences analyst...